Contraceptives - US - July 2012
US $4,395.00 (Excl.Tax)Excl. Tax Buy Now
Sales in a variety of categories declined during the recession. However sales of OTC contraceptives spiked in 2009 and continued to grow in 2010 and 2011. While this growth is encouraging, it is also apparent that few manufacturers and retailers have been able to fully capitalize on growing demand for sexual health and wellness products that help protect against pregnancy and, in some cases, add to sexual pleasure.
In order to provide insight that can be used to develop effective messaging and products that will resonate with contraceptive users, Mintel has published this report which addresses the following questions:
This report will give you a complete 360-degree view of your market. Not only is it rooted in robust proprietary and high-quality third-party data, but our industry experts put that data into context and you’ll quickly understand:
What They Want. Why They Want It.
Who’s Winning. How To Stay Ahead.
Size, Segments, Shares And Forecasts: How It All Adds Up.
New Ideas. New Products. New Potential.
Where The White Space Is. How To Make It Yours.
What’s Shaping Demand – Today And Tomorrow.